Work

Combining Bioactive Cell-Penetrating Peptides and Vemurafenib to Produce Peptide–Drug Conjugates with Activity Against Drug-Resistant Melanoma Cells

Year: 2025

Type: article

Source: Journal of Medicinal Chemistry

DOI: 10.1021/acs.jmedchem.5c02367

Authors: Isabella R. Palombi, Andrew M. White, Yasuko Koda, David J. Craik, Sónia Troeira Henriques, Nicole Lawrence, Lara R. Malins

Institutions: Australian National University, Australian Research Council, The University of Queensland, ARC Centre of Excellence for Innovations in Peptide and Protein Science, Institute for Molecular Bioscience, Translational Research Institute, Queensland University of Technology

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Australian Government, Snow Medical, Australian Research Council, National Health and Medical Research Council, Congressionally Directed Medical Research Programs

Awards: ARC Centre of Excellence for Innovations in Peptide and Protein Science, Advancing peptide-based drug design, G5368869171, G8663845830

OpenAlex ID: W4415648549

FWCI: 1.044

Cites: 57

Cited by: 4

Related to: